Contact
For business, media, or testing-related inquiries, please get in touch.
VALIDATION
Multiple studies and commercial installations demonstrate C-POLAR™ material effectively captures viruses, microorganisms, and pollens, with up to 99.99% efficiency
Lab Validation
The study showed C-POLAR™ material captured 92% of Staphylococcus aureus after a 10-minute incubation period. The input of pathogens was close to 100x higher than the ISO 20743:2013 standard.
92%
CAPTURE
The study showed filters protected by C-POLAR™ significantly improved collection efficiency and substantially reduced viable bovine coronavirus concentration by 99.3% in a single-pass, fast air-flow wind tunnel.
99.3%
CAPTURE
The study showed C-POLAR™ material captured >99.6% of SARS-CoV-2 within 30 minutes (98% within 5 minutes). In one of the biological replicates, researchers achieved 100% virus capture rate.
99.6%
CAPTURE
The study showed C-POLAR™ material captured >99.9% of multiple bacterial pathogens within 1 minute.
99.9%
CAPTURE
The study showed C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.
99.9%
CAPTURE
The study showed C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.
99.9%
CAPTURE
COMMERCIAL VALIDATION
Working in partnership with Hong Kong Metropolitan University, we installed filters protected by C-POLAR™ in five dense foot traffic locations in Hong Kong: International Commerce Center, Central Building, K11 MUSEA, 1 Duddell Street, and China Minmetals Tower.
Studies showed filters protected by C-POLAR™ demonstrated strong effectiveness against pathogens of up to 99.9999%, even after 60 days of intensive, real-world commercial use in bioaerosol and particulate rich environments.
